The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HSCT

NCT03902041 · clinicaltrials.gov ↗

UNKNOWN

Status

160

Enrollment

OTHER_GOV

Sponsor class

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation
Eltrombopag

Interventions

DRUG: Eltrombopag

Sponsor

Shandong Provincial Hospital